Arrowhead Research | ARWR - Kapitał Własny I Rezerwy





Kapitał Własny I Rezerwy Zmiana Data
Agios Pharmaceuticals USD 1.03B 83.09M 2026-06
Alnylam Pharmaceuticals USD 1.35B 278.74M 2026-06
Anika Therapeutics USD 137.28M 3.38M 2026-06
Arrowhead Research USD 465.53M 148.45M 2026-06
Heron Therapeutics USD 6.91M 2.23M 2026-06
Incyte USD 6.34B 721.58M 2026-06
Ionis Pharmaceuticals USD 439.74M 51.68M 2026-06
Ligand Pharmaceuticals USD 967.52M 29.81M 2026-06
Merck USD 41.93B 3.94B 2026-06
Moderna USD 6.76B 647M 2026-06
Nektar Therapeutics USD 576.22M 486.38M 2026-03
Novartis USD 41.95B 3.02B 2026-06
Sarepta Therapeutics USD 1.53B 22.7M 2026-06
TG Therapeutics USD 604.08M 20.95M 2026-06
Ultragenyx Pharmaceutical USD -291M 55M 2026-06
Vertex Pharmaceuticals USD 20.25B 886M 2026-06
Xencor USD 503.23M 12.4M 2026-06